Cargando…
Overall Survival Improved for Contemporary Patients with Melanoma: A 2004–2015 National Cancer Database Analysis
INTRODUCTION: Since 2011, encouraging clinical trial results have led to approval of multiple new therapies for advanced melanoma, but the impact of these therapies outside of trial populations is largely unknown. This study examines use of novel therapies and survival in contemporary patients with...
Autores principales: | Farrow, Norma E., Turner, Megan C., Salama, April K. S., Beasley, Georgia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683754/ https://www.ncbi.nlm.nih.gov/pubmed/32700043 http://dx.doi.org/10.1007/s40487-020-00117-1 |
Ejemplares similares
-
Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma
por: Beasley, Georgia M, et al.
Publicado: (2021) -
Predictive factors of neoadjuvant immune checkpoint blockade in melanoma
por: Sarver, Melissa, et al.
Publicado: (2021) -
Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the National Health Information Database
por: Kim, Byung-Woo, et al.
Publicado: (2019) -
Prevalence of Missing Data in the National Cancer Database and Association With Overall Survival
por: Yang, Daniel X., et al.
Publicado: (2021) -
Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients
por: Hoeh, Benedikt, et al.
Publicado: (2021)